The company is now focused on advancing this therapy into the next phase of clinical development to address the high unmet need in Crohn's disease ... This provides a differentiated, non-immunosuppressive therapeutic pathway for Crohn's disease.
New medical guidelines now recommend starting moderate-to-severe Crohn's disease patients on powerful biologic drugs first, bypassing older conven... .
Monday marks the start of Crohn's and Colitis Awareness Week, which aims to raise awareness of the everyday struggles faced by people living with the conditions ... .
WHEREAS, Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), affect nearly 1 in 100Americans, and. WHEREAS, Crohn's disease is a chronic inflammatory ...
Designed to help educators support students living with Crohn's disease and ulcerative colitis, this guide includes tips on understanding IBD, promoting inclusion, and encouraging self-advocacy ... About Crohn's and Colitis in Canada.
(BPT) - Sponsored by Merck ... It affects about 10 million people around the world.[1],[2] The two main types of IBD are ulcerative colitis (UC) and Crohn's disease (CD). × This page requires Javascript ... Please enable it in your browser settings ... .